National CineMedia reported a 269.6% year-over-year increase in revenue for Q2 2024, beating analyst estimates. However, EPS of -$0.09 missed expectations. The company's advertising revenue metrics were mixed compared to analyst projections.

National CineMedia (NCMI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Here is how National CineMedia (NCMI) and FiscalNote Holdings, Inc. (NOTE) have performed compared to their sector so far this year.

The headline numbers for National CineMedia (NCMI) give insight into how the company performed in the quarter ended March 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.

Publicis Groupe, National CineMedia and AdTheorent Holding are part of the Zacks Industry Outlook article.

The Zacks Advertising and Marketing industry is expected to gradually reach the pre-pandemic healthy levels with an increase in service activities. PUBGY, NCMI and ADTH are likely to ride on the digital marketing surge and client-centric strategies.

As of March 21, 2024, three stocks in the communication services sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compared to a stock's price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered overbought when the RSI ...

Ratings for National CineMedia (NASDAQ:NCMI) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 0 1 0 0 0 1M Ago 1 0 2 0 0 2M Ago 0 0 0 0 0 3M Ago 0 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $5.69, a high estimate of $6.75, and a low estimate of $4.50. This current average has increased by 26.44% from the previous average price target of $4.50. Diving into Analyst Ratings: An In-Depth Exploration The standing of National CineMedia among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Mike Hickey Benchmark Maintains Speculative Buy $6.00 - Michael Pachter Wedbush Raises Neutral $5.50 $4.50 Eric Wold B. Riley Securities Raises Buy $6.75 $4.50 Michael Pachter Wedbush Maintains Neutral $4.50 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to National CineMedia. This insight ...Full story available on Benzinga.com

Shares of Peraso Inc. (NASDAQ: PRSO) fell sharply during Tuesday’s session after the company reported worse-than-expected fourth-quarter EPS results. Peraso posted a quarterly loss of $8.52 per share, versus analysts’ estimates for a loss of $3.76 per share. The company’s quarterly sales came in at $1.83 million versus expectations of $1.70 million. Peraso shares tumbled 23.3% to $1.32 on Tuesday. Here are some other stocks moving in today's mid-day session. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares climbed 197.8% to $0.5660 ahead of the company's presentation at the 36th Annual Roth Conference. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) gained 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. SCWorx Corp. (NASDAQ: WORX) gained 74% to $3.22. Spire Global, Inc. (NYSE: SPIR) climbed 50.7% to $18.50 after announcing a collaboration with NVIDIA to advance AI-driven weather prediction. Enveric Biosciences, Inc (NASDAQ: ENVB) shares climbed 43.6% to $1.5801 after the company announced that it signed two non-binding term sheets with an undisclosed biotechnology company to pursue the out-licensing of cannabinoid-COX-2 conjugate compounds for pharmaceutical and non-pharmaceutical applications for the treatment of joint diseases. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 33.1% to $1.57 after the company announced that it partnered with EaseMyTrip to integrate its cars within the travel platform. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 32% to $1.51 after the company announced pre-clinical research showcasing the potential of HT-ALZ in Alzheimer's disease. Enliven Therapeutics, Inc. (NASDAQ: ELVN) gained 27.2% to $16.09. The company announced a $90 million private placement financing and provided pipeline updates. National CineMedia, Inc. (NASDAQ: NCMI) gained 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Alignment Healthcare, Inc. (NASDAQ: ALHC) gained 17.7% to $5.50. Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) rose 15% to $43.63 ...

National CineMedia, Inc. (NASDAQ: NCMI) posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. Operating revenue stood at $90.9 million, beating the consensus of $81.1 million. EPS of 24 cents beat the consensus of 9 cents, according to data from Benzinga Pro. For the first quarter of 2024, NCM expects revenue of $34.5 million-$35.5 million (vs. consensus of $32.47 million) and adjusted OIBDA loss in the range of $(7.5) million to $(6.5) million. “In 2023, NCM successfully re-established the importance of cinema for best-in-class advertisers, with movies driving the cultural ...

U.S. stocks were mixed, with the Dow Jones index gaining around 75 points on Tuesday. Shares of National CineMedia, Inc. (NASDAQ: NCMI) jumped 25.5% to $5.30 after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. Operating revenue stood at $90.9 million, beating the consensus of $81.1 million. EPS of 24 cents beat the consensus of 9 cents. The company said it sees first-quarter total revenue of $34.5 million to $35.5 million. Here are some other big stocks recording gains in today’s session. Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) shares jumped 97.3% to $20.99 after the company announced agreed to be acquired by AstraZeneca. Also, Leerink Partners downgraded the stock from Outperform to Market Perform but raised its price target from $17 to $21. Spire Global, Inc. (NYSE: SPIR) shares climbed 50.7% to $18.50 after announcing ...

Shares of Fusion Pharmaceuticals Inc. (NASDAQ: FUSN) rose sharply in today’s pre-market trading after the company agreed to be acquired by AstraZeneca for around $2 billion in cash. Fusion Pharmaceuticals shares jumped 94.5% to $20.71 in pre-market trading Here are some other stocks moving in pre-market trading. Gainers Ontrak, Inc. (NASDAQ: OTRK) shares rose 84.2% to $0.35 in pre-market trading. Zoomcar Holdings, Inc. (NASDAQ: ZCAR) rose 59.3% to $1.88 in pre-market trading. EaseMyTrip announced a strategic partnership with Zoomcar to provide pre-booked and on-demand self-drive cars in India. Chijet Motor Company, Inc. (NASDAQ: CJET) shares rose 26.8% to $0.7357 in pre-market trading after gaining 18% on Monday. Li-Cycle Holdings Corp. (NASDAQ: LICY) climbed 25.5% to $1.38 in pre-market trading after the company issued a business update, following announcement of $75 million investment from Glencore. National CineMedia, Inc. (NASDAQ: NCMI) gained 23.2% to $5.20 in pre-market trading after the company posted upbeat results for its fourth quarter and disclosed a new $100 million share repurchase program. The company said it sees first-quarter total ...